HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells.

AbstractBACKGROUND/AIMS:
Baicalein has been shown to possess significant anti-hepatoma activity by inhibiting cell proliferation. Whether the anti-proliferative effect of baicalein is related to its modulation of miRNA expression in hepatocellular carcinoma (HCC) is still unknown.
METHODS:
The anti-proliferative effects of baicalein on HCC cell line Bel-7402 was assessed by detecting the proliferation activity, cell cycle distribution, expression changes of p21/CDKN1A, P27/CDKN1B, total Akt and phosphoryted AKT. Microarray analysis was conducted to determine the miRNA expression profiles in baicalein-treated or untreated Bel-7402 cells and then validated by qRT-PCR in two HCC cell lines (Bel-7402 and Hep3B). The gain-of-function of miR-3127-5p was performed by detecting anti-proliferative effects after transfecting miRNA mimics in cells. Finally, the expression level of miR-3127-5p in different HCC cell lines was determined by qRT-PCR.
RESULTS:
Baicalein was able to inhibit the proliferation of Bel-7402 cells by inducing cell cycle arrest at the S and G2/M phase via up-regulating the expression of p21/CDKN1A and P27/CDKN1B and suppressing the PI3K/Akt pathway. Baicalein could alter the miRNA expression profiles in Bel-7402 cells. Putative target genes for differentially expressed miRNAs could be enriched in terms of cell proliferation regulation, cell cycle arrest and were mainly involved in MAPK, PI3K-Akt, Wnt, Hippo and mTOR signaling pathways. MiR- 3127-5p, one of up-regulated miRNAs, exhibits low expression level in several HCC cell lines and its overexpression could inhibit cell growth of Bel-7402 and Hep3B cell lines by inducing S phase arrest by up-regulating the expression of p21and P27 and repressing the PI3K/Akt pathway.
CONCLUSIONS:
Modulation of miRNA expression may be an important mechanism underlying the anti-hepatoma effects of baicalein.
AuthorsBeibei Bie, Jin Sun, Jun Li, Ying Guo, Wei Jiang, Chen Huang, Jun Yang, Zongfang Li
JournalCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology (Cell Physiol Biochem) Vol. 41 Issue 4 Pg. 1519-1531 ( 2017) ISSN: 1421-9778 [Electronic] Germany
PMID28351032 (Publication Type: Journal Article)
Copyright© 2017 The Author(s)Published by S. Karger AG, Basel.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Flavanones
  • MIRN3127 microRNA, human
  • MicroRNAs
  • Neoplasm Proteins
  • RNA, Neoplasm
  • baicalein
Topics
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Carcinoma, Hepatocellular (drug therapy, metabolism)
  • Cell Cycle (drug effects)
  • Flavanones
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms (drug therapy, metabolism)
  • MAP Kinase Signaling System (drug effects)
  • MicroRNAs (biosynthesis)
  • Neoplasm Proteins (biosynthesis)
  • RNA, Neoplasm (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: